About Denali Therapeutics Inc
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- South San Francisco, California
- Founded
- 2015
- Company type
- Public Company
- Company profile name
- Denali Therapeutics
Denali Therapeutics is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using our proprietary TransportVehicle™ platform. We discover, develop and deliver medicines for people living with neurodegenerative, lysosomal storage and other serious diseases.
Specialties
- Biotechnology
- Neurodegenerative Disease
- Neurodegeneration
- and Pharmaceuticals
Company locations
161 Oyster Point Blvd, South San Francisco, California 94080, US
5843 W Amelia Earhart Dr, Salt Lake City, Utah 84116, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Diagnostics
- Biotechnology
- Genetics
- Therapeutics
On LinkedIn
- Followers
- 65,670
- People linked to this company
- 598
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
1,322,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.